These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34751112)

  • 21. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis.
    Tomasetti M; Amati M; Santarelli L; Neuzil J
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.
    Rupaimoole R; Slack FJ
    Nat Rev Drug Discov; 2017 Mar; 16(3):203-222. PubMed ID: 28209991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA replacement therapy in cancer.
    Mollaei H; Safaralizadeh R; Rostami Z
    J Cell Physiol; 2019 Aug; 234(8):12369-12384. PubMed ID: 30605237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
    Bertoli G; Cava C; Castiglioni I
    Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.
    Ding L; Gu H; Xiong X; Ao H; Cao J; Lin W; Yu M; Lin J; Cui Q
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.
    Fang Y; Zhang L; Li Z; Li Y; Huang C; Lu X
    Int Rev Cell Mol Biol; 2017; 333():1-49. PubMed ID: 28729023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
    Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNA genetic alterations in human cancers.
    Giannakakis A; Coukos G; Hatzigeorgiou A; Sandaltzopoulos R; Zhang L
    Expert Opin Biol Ther; 2007 Sep; 7(9):1375-86. PubMed ID: 17727327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs: Their Role in Metastasis, Angiogenesis, and the Potential for Biomarker Utility in Bladder Carcinomas.
    Hammouz RY; Kołat D; Kałuzińska Ż; Płuciennik E; Bednarek AK
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA dysregulation in gastric cancer: a new player enters the game.
    Wu WK; Lee CW; Cho CH; Fan D; Wu K; Yu J; Sung JJ
    Oncogene; 2010 Oct; 29(43):5761-71. PubMed ID: 20802530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating cancer with microRNA replacement therapy: A literature review.
    Hosseinahli N; Aghapour M; Duijf PHG; Baradaran B
    J Cell Physiol; 2018 Aug; 233(8):5574-5588. PubMed ID: 29521426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.
    Wang D; Qiu C; Zhang H; Wang J; Cui Q; Yin Y
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Analysis of microRNA Binding Site Distribution and microRNA-Mediated Gene Expression Repression of Oncogenes and Tumor Suppressor Genes.
    Tian S; Wang J; Zhang F; Wang D
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.
    Weng W; Feng J; Qin H; Ma Y; Goel A
    Future Oncol; 2015; 11(12):1791-808. PubMed ID: 26075447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs Determining Carcinogenesis by Regulating Oncogenes and Tumor Suppressor Genes During Cell Cycle.
    Fasoulakis Z; Daskalakis G; Diakosavvas M; Papapanagiotou I; Theodora M; Bourazan A; Alatzidou D; Pagkalos A; Kontomanolis EN
    Microrna; 2020; 9(2):82-92. PubMed ID: 31538910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional regulation of nuclear miRNAs in tumorigenesis (Review).
    Liu J; Yang T; Huang Z; Chen H; Bai Y
    Int J Mol Med; 2022 Jul; 50(1):. PubMed ID: 35593304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.